intuitive surgical investor presentation 2021

Intuitive advances minimally invasive care by innovating at the point of possibility. We continue to see significant utilization variance by region due to pandemic differences. So from a core demand point of view or disease state, that's clearly out there and accumulating, and it has to get processed through. Our digital learning programs continue to be an important part of our overall learning initiatives. The Company ended the first quarter of 2022 with $8 .40 billion in cash, cash equivalents, and investments, a decrease of $218 . Based on market data, we believe that diagnostic pipelines in the U.S. began to recover from the impact of the pandemic in March, with a lag in the recovery of associated procedures. Fourth quarter 2021 instruments and accessories revenue increased by 13% to $843million, compared with $747million in the fourth quarter of 2020, primarily driven by approximately 19% growth in da Vinci procedure volume, partially offset by stocking orders in the prior year associated with the Companys launch of Extended Use Instruments. And I think for a subset of the benign procedures that have been kind of deferred elective procedures, hospitals can recover those pretty quickly. Our focus right now is not rapid expansion of the installed base. In the U.S., procedures that are dependent on diagnostic pipelines also grew, albeit at lower rates as compared to benign procedures. Ion system placements and procedures are excluded from our overall system and procedure counts. The Company grew its da Vinci Surgical System installed base to 7,544 systems as of, Fourth quarter 2022 GAAP net income attributable to Intuitive was, Fourth quarter 2022 non-GAAP* net income attributable to Intuitive was. Copyright 2023 Intuitive Surgical. These awards are valued based on certain key performance metrics. 2021 Intuitive Sustainability Report 7.8 MB. I think that's what's been driving our success in the early market. There was the usual impact of seasonality from vacations like Easter, but nothing notable within the quarter. The Company shipped 385 da Vinci Surgical Systems in the fourth quarter of 2021, compared with 326 systems in the fourth quarter of 2020. The Motley Fool has a disclosure policy. Listen to Webcast. That said, other teams are out. Turning to our innovation and commercialization efforts. It is in fact a physically taxing procedure, as Gary described. This growth rate compares with 9% last year and 8% last quarter. And regarding the backlog, how do you know there was catch-up and why won't that continue for the next few quarters? From a market perspective, about 60%-ish or so are sleeves, about 15% are revisions. Intuitive Surgical, and Verb Surgical, among other countless innovations. Recovery in the U.K. was healthy in the quarter as NHS increased access to surgeries broadly. your options for e-mail notification, please enter your e-mail address below and click So first question for me is just trying to dissect your procedure results a little bit more because some really interesting comments, that you saw strength in benign cases, some catch-up cases. PROCEPT BioRobotics is a surgical robotics company enabling better patient care by developing transformative solutions in urology. Based in Sunnyvale, California. Now turning to the clinical side of our business. (4) Income tax expense includes the effect of the following items: One-time tax benefit from re-measurement of certain deferred tax assets, Discrete tax expense arising from the conclusion of a tax matter, Accounts payable and other accrued liabilities, Total liabilities and stockholders equity, Adjustments attributable to noncontrolling interest in joint venture. Growth in the U.K. was strong, with a slower recovery in France, Italy, and Germany. The stock split will take place after market close on October 5th, 2021. My name is Kari Krogstad. It's a highly penetrated laparoscopic indication in the United States. My Intuitive allows surgeons and care team members to access their data, to manage their profile, their learning, and otherwise interact with Intuitive through an easy-to-use mobile app in the palm of their hand. The constant currency revenue percentage change is calculated by determining the increase in the current period constant currency revenue over the prior period revenue. To choose You may automatically receive Intuitive Surgical financial information by e-mail. INTUITIVE at 2022 Wells Fargo Healthcare Conference. And we've seen both good clinical outcomes, but also high surgeon satisfaction and better ergonomics. And U.S. general surgery, in particular, performed well. On the why side, it's -- bariatrics has been a little different than other procedure for us. Fourth quarter 2022 non-GAAP* income from operations decreased to $530 million, compared with $583 million in the fourth quarter of 2021. First cases in our SP colorectal IDE trial were completed in the quarter as we seek to bring SP capability to additional procedures. So short answer there is just kind of a reminder of what we're trying to do. We've seen that in some OUS markets. Intuitive will hold a teleconference at 1:30 p.m. PST today to discuss the fourth quarter 2021 financial results. Later we will have a question-and-answer session. And that if it hasn't delivered against the Quad Aim, if these systems can do some cases well, but not all cases well or they have stability issues or other things, that wears in pretty quickly. I'm here together with my CFO, Thomas Jakobsen.. | 2 Mrz 2023 . How are you thinking about competition? Jamie Samath -- Senior Vice President of Finance. Dec 2017 - Aug 20213 years 9 months. Please see our Terms and Conditions for additional details, including our Obligatory Capitalized Disclaimers of Liability. For more information, please visit the Companys website at www.intuitive.com. Turning to our single-port system. Copyright 2023 Intuitive Surgical. See www.intuitive.com/trademarks. Jamie will discuss procedure and clinical highlights and provide an update of our financial outlook. Senior Director-Finance & Investor Relations: Julian N. Nikolchev: Senior VP-Corporate Development & Strategy: As I conclude, for the balance of the year, we're focused on the following: first, agile and flexible support for our customers globally as they need it, often addressing the return of surgical patients to treatment. European procedure growth was generally healthy, though varied by country. The Company believes that both management and investors benefit from referring to these non-GAAP financial measures in assessing its performance and when planning, forecasting, and analyzing future periods. Q4 2022 INTUITIVE Earnings Conference Call, INTUITIVE at J.P. Morgan Healthcare Conference, Q3 2022 INTUITIVE Earnings Conference Call, INTUITIVE at 2022 Wells Fargo Healthcare Conference, Q2 2022 INTUITIVE Earnings Conference Call, INTUITIVE at 43rd Annual Goldman Sachs Global Healthcare Conference, INTUITIVE at BofA Securities 2022 Healthcare Conference, Q1 2022 INTUITIVE Earnings Conference Call. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release and which are based on current expectations and are subject to risks, uncertainties, and assumptions that are difficult to predict, including those risk factors identified under the heading Risk Factors in the Companys Annual Report on Form 10-K for the year ended December31, 2021, and the Companys Quarterly report on Form 10-Q for the quarter ended September 30, 2022, as updated by the Companys other filings with the Securities and Exchange Commission. Frankly, the lack of precision in that estimate is such that it's probably not useful for us to share. The outlook we are providing on today's call does not reflect risks associated with a significant increase in COVID-related hospitalizations in relation to the Delta variant or other potential new variants. 06/14/22 - 1:20 PM PDT. I think the product ecosystem with XI with a 60-millimeter stapler is in good shape, and we're getting good feedback from surgeons in that regard. We continue to operate in a challenging supply chain environment and have experienced longer lead times and delayed deliveries from our suppliers. The compounded annual utilization growth rate between the second quarters of 2019 and 2021 was 6%. Investor's Business Daily . Thoracic Surgery Market was valued at USD 3.1 Billion in 2021, and it is expected to reach a CAGR of 7.18 % . Our installed base of SP Systems is now 79: eight in Korea and 71 in the U.S. We completed first cases associated with a U.S. colorectal clinical trial in the second quarter. as can be seen with the more than 29,000 peer-reviewed scientific articles that reference Intuitive technologies. Fourth quarter 2022 GAAP net income attributable to Intuitive Surgical, Inc. was $325 million, or $0.91 per diluted share, compared with $381 million, or $1.04 per diluted share, in the fourth quarter of 2021. Roughly a third of our team works in the manufacturer test and distribution of our products. Third, driving depth and excellence in regional performance, particularly in Europe and Asia. Intuitive Announces Fourth Quarter Earnings, www.intuitive.com/en-us/products-and-services/ion, Less: net income (loss) attributable to noncontrolling interest in joint venture. [Inaudible] on a nice quarter. To change your e-mail options at Product and brand names/logos are trademarks or registered trademarks of Intuitive Surgical or their respective owner. Mai 2022: CI. And so we'll see over time, we'll be able to measure a little bit better over time, and we'll monitor it. I don't know how much of an update you can give us, but just something on what's happening at that level in terms of software tools and services? To change your e-mail options at Fourth quarter 2021 GAAP income from operations included share-based compensation expense of $120 million, compared with $104 million in the fourth quarter of 2020. . Thank you. Instrument and accessory revenue per procedure of $1,940 increased, compared with $1,900 per procedure for the second quarter of last year, and decreased, compared with $1,950 per procedure in the first quarter. Reported revenue and procedure results are consistent with the Companys press release issued on January 12, 2022. In the past 60 days, the Zacks Consensus Estimate for its earnings has moved north by 8.4% to $14.72. So it's not a scientific study, just my view. Fourth quarter 2022 revenue was$1.66 billion, an increase of 7%compared with$1.55 billion in thefourth quarter of 2021. We heard your comments, but just kind of thinking a little bit longer-term than just the next couple of quarters. Fourth quarter 2021 GAAP net income attributable to Intuitive Surgical, Inc. included excess tax benefits of $27 million, or $0.07 per share, compared with $21 million, or $0.06 per share, in the fourth quarter of 2020. In reporting the results, adjusted using a propensity weighted approach, the authors noted that during the two- to four-week standard of care visit period, fewer patients report the need to take prescription pain medication for the robotic cohort as compared to the laparoscopic and open cohorts: 65.2% for the robotic cohort as compared to 78.8% for the laparoscopic cohort, compared to 79.8% for the open cohort. Intuitive Surgical's adjusted net income of $435 million in Q3 2021 reflected a good 30% rise from its $334 million figure in the prior-year quarter. Gross profit, income from operations, net income attributable to Intuitive Surgical, Inc., net income per diluted share attributable to Intuitive Surgical, Inc., and diluted shares are reported on a GAAP and non-GAAP* basis. Our teams continue to work closely with hospitals, physicians, and care teams in pursuit of what our customers have termed the Quadruple Aim: Better, more predictable patient outcomes, better experiences for patients, better experiences for their care teams, and ultimately, a lower total cost to treat. The Company undertakes no obligation to publicly update or release any revisions to these forward-looking statements, except as required by law. The Motley Fool recommends Johnson & Johnson and recommends the following options: long January 2022 $580 calls on Intuitive . Another third works closely with customers in the field, and the remaining third have traditionally worked in lab and office environments. OK. That's helpful. Invest better with The Motley Fool. Our pro forma spending grew over 24% from a year ago, representing increased investment in our business. Gary, just with you, just thinking through the My Intuitive and what you're doing at the surgeon level. However, that charge generated -- that change generated a long-term benefit of $66 million that is recognized currently in GAAP income and will be recognized ratably over approximately 10 years in pro forma income. Product and customer mix fluctuate quarter to quarter, which can cause fluctuations in gross margins. That says that we're not putting out more capital than folks need, even though it's been healthy capital quarters, it means our customers are getting good benefit out of what they're using those systems for. INTUITIVE SURGICAL, INC.UNAUDITED QUARTERLY CONDENSED CONSOLIDATED STATEMENTS OF INCOME (IN MILLIONS, EXCEPT PER SHARE DATA), INTUITIVE SURGICAL, INC.UNAUDITED TWELVE MONTHS ENDED CONDENSED CONSOLIDATED STATEMENTS OF INCOME (IN MILLIONS, EXCEPT PER SHARE DATA), INTUITIVE SURGICAL, INC.UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (IN MILLIONS), INTUITIVE SURGICAL, INC.UNAUDITED RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES(IN MILLIONS, EXCEPT PER SHARE DATA), Contact: Investor Relations(408) 523-2161. Jan 2023 - Present3 months. INTUITIVE SURGICAL, INC.UNAUDITED QUARTERLY CONDENSED CONSOLIDATED STATEMENTS OF INCOME(IN MILLIONS, EXCEPT PER SHARE DATA), INTUITIVE SURGICAL, INC.UNAUDITED TWELVE MONTHS ENDED CONDENSED CONSOLIDATED STATEMENTS OF INCOME(IN MILLIONS, EXCEPT PER SHARE DATA), INTUITIVE SURGICAL, INC.UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS(IN MILLIONS), INTUITIVE SURGICAL, INC.UNAUDITED RECONCILIATION OF GAAP FINANCIAL MEASURES TO NON-GAAP FINANCIAL MEASURES(IN MILLIONS, EXCEPT PER SHARE DATA), Contact: Investor Relations(408) 523-2161. To change your e-mail options at SUNNYVALE, Calif., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Intuitive (the "Company") (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended December 31, 2021.Reported revenue and procedure results are consistent with the Company's press release issued on January 12, 2022.

Georgia Tech Mgt 6203 Syllabus, Long Beach Beach Volleyball Schedule, Articles I

intuitive surgical investor presentation 2021